Index. Note: Page numbers of article titles are in boldface type.
|
|
- Michael Stevens
- 5 years ago
- Views:
Transcription
1 Index Note: Page numbers of article titles are in boldface type. A Accelerated intravascular coagulation and fibrinolysis (AICF) in liver disease, Acid suppression in liver disease, ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) ALF and, CLD and, 345 defined, in liver disease causes of, diagnosis of, epidemiology of, staging of, Acute liver failure (ALF) AKI and, B-ECLS in, cerebral edema in, 313 CT in, described, 440 ECLS systems in, (See also Extracorporeal liver support (ECLS) systems, in ALF and ACLF) HE in, 313 intracranial hypertension in evaluation of serial laboratory testing in, 314 risk factors for, 314 invasive neuromonitoring in, 318 management of plasma ammonia lowering strategies in, 323 MARS and, mortality related to, 313 MRI in, 318 neuroprotective strategies in, 320 noninvasive neuromonitoring in, 320 Acute-on-chronic liver failure (ACLF), clinical studies of MARS and, decompensated chronic liver failure vs., defined, 301 described, 440 Crit Care Clin 32 (2016) /16/$ see front matter criticalcare.theclinics.com
2 476 Index Acute-on-chronic (continued ) ECLS systems in, (See also Extracorporeal liver support (ECLS) systems, in ALF and ACLF) infections in liver disease and, 416 Acute renal function in liver disease diagnosis and staging of, Acute respiratory distress syndrome (ARDS) considerations in postoperative management of liver transplant patients, 460 Advanced liver disease, See also Liver disease(s), advanced AEDs. See Antiepileptic drugs (AEDs) AICF. See Accelerated intravascular coagulation and fibrinolysis (AICF) AKI. See Acute kidney injury (AKI) Albumin in infections in liver disease management, 418 Albumin hypothesis detoxification and, ALF. See Acute liver failure (ALF) Alternative pathway therapy Analgesics in liver disease, 402 Anion gap metabolic acidosis in liver disease, 349 Antiarrhythmics in liver disease, 403 Antibiotics ammonia-lowering in overt type C HE management in ICU, 324 in infections in liver disease management, Anticoagulation in liver disease, 405 Antiemetics in liver disease, 404 Antiepileptic drugs (AEDs) in liver disease, 399 ARDS. See Acute respiratory distress syndrome (ARDS) Arrhythmias considerations in postoperative management of liver transplant patients, Artificial extracorporeal liver support (ECLS) systems in ALF and ACLF, adverse effects of, Ascites cause of, 334 Autoimmune disease cirrhosis due to, 303 B Balloon tamponade in esophageal varices management in liver disease, 375
3 Index 477 B-ECLS. See Bioartificial extracorporeal liver support (B-ECLS) Biliary complications in liver transplant patients, Bioartificial extracorporeal liver support (B-ECLS) in ALF, design of, Bleeding coagulopathy in liver disease and, 390 in liver disease management of, b-blockers in liver disease, 403 C Cardiac cirrhosis, Cardiac dysfunction latent in liver disease, 336 in liver disease, 334 clinical implications of, Cardiomyopathy cirrhotic pathophysiology of, 337 Cardiovascular medications in liver disease, Cardiovascular system considerations in postoperative management of liver transplant patients, liver dysfunction in critically ill patients effects on, Cerebral edema in ALF and type C HE, 313 Chronic liver disease (CLD) AKI and, 345 Chronic liver failure decompensated, vs. acute-on-chronic liver failure, Circulatory failure infections in liver disease and, 416 Circulatory system in liver disease, Cirrhosis, cardiac, causes for, introduction, risk factors for, Cirrhosis-associated immunodeficiency pathogenesis of, 414 Cirrhosis-induced systemic inflammation pathogenesis of, Cirrhotic cardiomyopathy pathophysiology of, 337
4 478 Index CLD. See Chronic liver disease (CLD) Coagulation management of in postoperative management of liver transplant patients, 464 Coagulation factors in liver disease, liver dysfunction in critically ill patients effects on, 434 Coagulopathy infections in liver disease and, 417 in liver disease clinical implications of, Computed tomography (CT) in ALF and overt type C HE, Continuous renal replacement therapy (CRRT) in overt type C HE management in ICU, Critically ill patients liver dysfunction in, coagulation effects of, 434 infectious diseases effects of, introduction, 425 nutritional effects of, organ systems effects of, cardiovascular, endocrine, 434 GI, hepatic, 433 neurologic, renal, respiratory, 432 rehabilitation effects of, 435 CT. See Computed tomography (CT) D Detoxification albumin hypothesis and, Diastolic dysfunction in liver disease, 337 DIC. See Disseminated intravascular coagulation (DIC) Disseminated intravascular coagulation (DIC) in liver disease, Dysmotility in liver disease, E ECLS systems. See Extracorporeal liver support (ECLS) systems Edema cerebral in ALF and type C HE, 313
5 Index 479 Electrophysiologic abnormalities in liver disease, 337 Embolizing large spontaneous portosystemic shunts Encephalopathy hepatic, (See also Hepatic encephalopathy (HE)) Endocrine system liver dysfunction in critically ill patients effects on, 434 Esophageal varices in liver disease, introduction, 372 management of, balloon tamponade in, 375 rescue therapies in, 375 TIPS in, 375 Extracorporeal liver support (ECLS) systems in ALF and ACLF, future directions in, pooling of data in meta-analysis, 447 rationale for, 440 artificial in ALF and ACLF, adverse effects of, bioartificial in ALF, design of, F Fibrinolysis in liver disease, 387 Fluid retention in liver failure, 334 Fractionated plasma separation and adsorption, Fungal infections in liver disease, 420 G Gastric varices in liver disease, Gastrointestinal (GI) bleeding in liver disease, esophageal varices and, management of antibiotics in, 419 nonvariceal in liver disease, Gastrointestinal (GI) issues in liver disease, , acid suppression,
6 480 Index Gastrointestinal (continued) antiemetics, 404 gastric varices, GI bleeding, nonvariceal, introduction, MARS, 404 nutritional concerns and dysmotility, Gastrointestinal (GI) system liver dysfunction in critically ill patients effects on, GI. See Gastrointestinal (GI) H HE. See Hepatic encephalopathy (HE) Hematological issues in liver disease, , coagulation factors, coagulopathy in clinical implications of, diagnosis of, fibrinolysis, 387 introduction, management of, mechanisms of, platelet issues, 387 vwf, 387 Hemodynamic resuscitation in infections in liver disease management, 418 Hemorrhage postoperative in liver transplant patients, 465 Heparin-induced thrombocytopenia in liver disease, 406 Hepatic encephalopathy (HE), classification of, 312 clinical features of, 313 evaluation of approach to, 313 neurologic assessment in, serial laboratory testing in objectives of, 314 infections in liver disease and, 417 introduction, 311 overt type C cerebral edema in, 313 clinical and laboratory assessment in, CT in, in ICU management of, mortality related to, 313
7 Index 481 MRI in, 318 neurologic assessment of, treatment of pharmacologic, 318, 320 Hepatic hydrothorax (HH), clinical manifestations of, 360 defined, 360 diagnosis of, pathophysiology of, 360 treatment of, Hepatopulmonary syndrome (HPS), clinical manifestations of, 358 considerations in postoperative management of liver transplant patients, described, 357 diagnosis of, 359 pathophysiology of, treatment of, Hepatorenal syndrome, causes of, defined, 348 diagnosis of, epidemiology of, management of, 349 HH. See Hepatic hydrothorax (HH) High-volume plasmapheresis (HVP), 445 HPS. See Hepatopulmonary syndrome (HPS) HVP. See High-volume plasmapheresis (HVP) Hydrocortisone in infections in liver disease management, 419 Hyperdynamic circulatory syndrome, collateral circulation in, 333 described, splanchnic vasodilatation in proposed mechanisms of, Hypertension considerations in postoperative management of liver transplant patients, intracranial (See Intracranial hypertension) portal pathophysiology of, 332 portopulmonary, (See also Portopulmonary hypertension (POPH)) Hypothermia therapeutic I ICU. See Intensive care unit (ICU) Immunodeficiency cirrhosis-associated pathogenesis of, 414
8 482 Index Immunosuppression considerations in postoperative management of liver transplant patients, Infection(s) in liver disease, consequences of, diagnosis of, epidemiology of, fungal infections, 420 incidence of, 412 introduction, 411 management of, antibiotics in, general approach to, pathogenesis of, prevalence of, 412 resistant infections, 413 risk factors for, SBP, 420 significance of, 412 special considerations, 420 types of, 413 Infectious disease(s) considerations in postoperative management of liver transplant patients, 465 liver dysfunction in critically ill patients effects on, medications for in liver disease, Inflammation systemic cirrhosis-induced pathogenesis of, Intensive care unit (ICU) liver disease in patients in hemodynamic monitoring of, overt type C HE management in, readmission to after liver transplantation, 466 Intracranial hypertension in ALF evaluation of serial laboratory testing in, 314 risk factors for, 314 management of, prevention of, K Ketoacidosis in liver disease, 349 Kidney(s) liver dysfunction in critically ill patients effects on,
9 Index 483 Kidney failure infections in liver disease and, Kidney injury in liver disease, (See also Acute kidney injury (AKI), in liver disease) L Left ventricular hypertrophy in liver disease, Liver in critical illness, (See also Critically ill patients, liver dysfunction in) Liver disease(s). See also Cirrhosis; specific types, e.g., Acute-on-chronic liver failure advanced clinical implications of, discussion, epidemiology of, AKI in, (See also Acute kidney injury (AKI), in liver disease) cardiac cirrhosis, cardiac dysfunction in, 334 clinical implications of, latent, 336 causes of, circulatory system in, cirrhotic cardiomyopathy pathophysiology of, 337 diastolic dysfunction in, 337 electrophysiologic abnormalities in, 337 fluid retention in, 334 GI issues in, (See also Gastrointestinal (GI) issues, in liver disease) hematological issues in, (See also Hematological issues, in liver disease) hyperdynamic circulatory syndrome and, in ICU patients hemodynamic monitoring of, infections in, (See also specific types and Infection(s), in liver disease) kidney function in assessment of, kidney injury in, (See also Acute kidney injury (AKI), in liver disease) left ventricular hypertrophy in, metabolic acidosis in, pharmacologic issues in, (See also Pharmacologic issues, in liver disease) renal replacement therapy in, respiratory complications in, (See also Respiratory complications, in liver disease) systolic dysfunction in, 336 Liver dysfunction in critically ill patients, (See also Critically ill patients, liver dysfunction in) Liver failure fluid retention in, 334 Liver kidney transplantation, Liver transplantation anesthesia technique in,
10 484 Index Liver (continued ) phases of procedure, 454 readmission to ICU after, 466 Liver transplant patients intraoperative management of, anesthesia technique in, personnel in, 454 phases of, 454 vascular access and monitors in, 456 perioperative care of, introduction, postoperative management of coagulation-related, 464 complications related to, readmission to ICU due to, 466 graft function in, immediate, infectious disease issues in, 465 protocols for, 458 special considerations, 466 system-based considerations in, cardiovascular system, immunosuppression, metabolic system, nervous system, renal system, 463 respiratory system, M Magnetic resonance imaging (MRI) in ALF and overt type C HE, 318 MARS. See Molecular adsorbent recirculating system (MARS) Medications liver disease effects of (See specific types and Pharmacologic issues, in liver disease) Metabolic acidosis in liver disease, Metabolic disease cirrhosis due to, 303 Metabolic system considerations in postoperative management of liver transplant patients, Metronidazole in overt type C HE management in ICU, 324 Micronutrient supplementation Molecular adsorbent recirculating system (MARS), 441 ACLF clinical studies and, ALF and, HVP, 445 inflammatory profile, 444 Prometheus,
11 Index 485 SPAD, 444 in liver disease, 404 MRI. See Magnetic resonance imaging (MRI) N Neomycin in overt type C HE management in ICU, 324 Nervous system considerations in postoperative management of liver transplant patients, Neurologic medications in liver disease, AEDs, 399 analgesics, 402 sedatives, 402 Neurologic system liver dysfunction in critically ill patients effects on, Neurotransmitter blockade Non anion gap metabolic acidosis in liver disease, Nutrition liver dysfunction in critically ill patients effects on, Nutritional concerns in liver disease, Nutritional support in infections in liver disease management, 419 P Peritonitis spontaneous bacterial in liver disease, 420 Pharmacologic issues in liver disease, (See also specific issues, e.g., Neurologic medications) cardiovascular medications, GI issues, hematologic issues, infectious disease related, introduction, neurologic medications, pharmacokinetic and pharmacodynamic alterations, absorption, 398 distribution, 398 metabolism/elimination, 399 pulmonary complications, 403 renal medications, Plasma ammonia lowering strategies in ALF management, 323
12 486 Index Plasma (continued) in overt type C HE management in ICU, Platelet issues in liver disease, 387 Pneumonia ventilator-associated considerations in postoperative management of liver transplant patients, 461 POPH. See Portopulmonary hypertension (POPH) Portal hypertension pathophysiology of, 332 Portopulmonary hypertension (POPH), clinical manifestations of, 363 considerations in postoperative management of liver transplant patients, 462 described, 362 diagnosis of, epidemiology of, 363 pathogenesis of, 363 treatment of, Portosystemic shunts embolizing large spontaneous Prometheus, Pulmonary complications in liver disease, 403 R Rehabilitation liver dysfunction in critically ill patients effects on, 435 Renal failure infections in liver disease and, Renal medications in liver disease, Renal replacement therapy in liver disease, Renal system considerations in postoperative management of liver transplant patients, 463 liver dysfunction in critically ill patients effects on, Renal tubular acidosis in liver disease, Rescue therapies in esophageal varices management in liver disease, 375 Respiratory complications in liver disease, (See also specific types, e.g., Hepatopulmonary syndrome (HPS)) HH, HPS, POPH, SBPL, 362 Respiratory compromise considerations in postoperative management of liver transplant patients,
13 Index 487 Respiratory failure infections in liver disease and, 417 Respiratory system considerations in postoperative management of liver transplant patients, ARDS, 460 HPS, respiratory compromise, VAP, 461 weaning from mechanical ventilatory support, 459 liver dysfunction in critically ill patients effects on, 432 Rifaximin in overt type C HE management in ICU, 324 S SBP. See Spontaneous bacterial peritonitis (SBP) SBPL. See Spontaneous bacterial pleuritis (SBPL) Sedatives in liver disease, 402 Shock infections in liver disease and, 416 Single-pass albumin dialysis (SPAD), 444 SPAD. See Single-pass albumin dialysis (SPAD) Splanchnic vasodilatation in hyperdynamic circulatory syndrome proposed mechanisms of, Spontaneous bacterial peritonitis (SBP) in liver disease, 420 Spontaneous bacterial pleuritis (SBPL), 362 Systemic inflammation cirrhosis-induced pathogenesis of, Systolic dysfunction in liver disease, 336 T Therapeutic hypothermia Thrombocytopenia heparin-induced in liver disease, 406 Thromboembolism venous in liver disease prevention of, 405 Thrombosis in liver disease, 391 management of, prevention of, 391 TIPS. See Transjugular intrahepatic protosystemic shunt (YIPS)
14 488 Index Transjugular intrahepatic protosystemic shunt (YIPS) in esophageal varices management in liver disease, 375 Transplantation liver (See Liver transplantation; Liver transplant patients) liver kidney, V VAP. See Ventilator-associated pneumonia (VAP) Varice(s) esophageal (See also Esophageal varices, in liver disease) in liver disease, Vascular anastomoses complications related to in liver transplant patients, Vasopressors in liver disease, 402 Venous thromboembolism (VTE) in liver disease prevention of, 405 Ventilator-associated pneumonia (VAP) considerations in postoperative management of liver transplant patients, 461 Viral disease cirrhosis due to, von Willebrand factor (vwf) in liver disease, 387 VTE. See Venous thromboembolism (VTE) vwf. See von Willebrand factor (vwf) W Wound complications in liver transplant patients,
Index. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACLF. See Acute-on-chronic liver failure (ACLF) Acute kidney injury (AKI) in ACLF patients, 967 Acute liver failure (ALF), 957 964 causes
More informationManagement of the Cirrhotic Patient in the ICU
Management of the Cirrhotic Patient in the ICU Peter E. Morris, MD Professor & Chief, Pulmonary, Critical Care and Sleep Medicine University of Kentucky Conflict of Interest Funding US National Institutes
More informationIndex. Crit Care Clin 19 (2003)
Crit Care Clin 19 (2003) 331 335 Index A ACVECC. See American College of Veterinary Emergency and Critical Care (ACVECC). Aging. See also Elderly; Geriatric critical care. respiratory function effects
More informationVARICEAL BLEEDING. Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta.
VARICEAL BLEEDING Ram Subramanian MD Hepatology & Critical Care Medical Director of Liver Transplant Emory University, Atlanta Disclosures: None OUTLINE Pathophysiology of portal hypertension Splanchnic
More informationAPPROPRIATE PATIENT SELECTION AS A KEY TO INCREASE THE BENEFIT/RISK RATIO FOR ELAD
APPROPRIATE PATIENT SELECTION AS A KEY TO INCREASE THE BENEFIT/RISK RATIO FOR ELAD Ram Subramanian M.D. Hepatology and Critical Care Emory University School of Medicine Atlanta, USA OUTLINE Review the
More informationTreating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC
Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC mino.mitri@ubc.ca No Conflict of Interest 157 patients 157 patients 6 transplanted Criteria Liver
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Abdomen, acute, in oncological surgery patients, critical care issues in, 101 102 Acquired factor VIII inhibitors, in critically ill cancer
More information2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives
2017 ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives Shock Syndromes and Sepsis, Pulmonary Disorders, Hepatic Failure/GI/Endocrine Emergencies, Supportive and
More informationPACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in
More informationACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives
ACCP/SCCM Critical Care Preparatory Review and Recertification Course Learning Objectives Module 1 Critical Care Pharmacy Evolution and Validation, Practice Standards, Training, and Professional Development,
More informationLiver Failure. The most severe clinical consequence of liver disease is liver failure:
Liver diseases I The major primary diseases of the liver are: - Viral hepatitis, - Nonalcoholic fatty liver disease (NAFLD), - Alcoholic liver disease, - Hepatocellular carcinoma (HCC) Hepatic damage also
More informationManagement of Cirrhotic Patients Undergoing Non-Transplant Surgery
Management of Cirrhotic Patients Undergoing Non-Transplant Surgery Jason S. Wakakuwa, M.D. Assistant Professor of Anesthesia Director, Transplant Anesthesia Beth Israel Deaconess Medical Center I have
More informationManagement of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide
Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications
More informationLiver failure &portal hypertension
Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute lung injury (ALI) transfusion-related, 363 372. See also Transfusion-related acute lung injury (TRALI) ALI. See Acute lung injury
More informationCHAPTER 7. End Stage Liver Disease in the ICU: Walking a Tightrope. Lynn A. Kelso, MSN, APRN, FCCM, FAANP University of Kentucky College of Nursing
CHAPTER 7 End Stage Liver Disease in the ICU: Walking a Tightrope Lynn A. Kelso, MSN, APRN, FCCM, FAANP University of Kentucky College of Nursing Besey Oren, Assistant Professor Istanbul University Health
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acute variceal bleeding management of, 251 262 balloon tamponade of esophagus in, 257 258 endoscopic therapies in, 255 257. See also Endoscopy,
More informationUCLA General Surgery Residency Program Rotation Educational Policy Goals and Objectives ROTATION: SURGICAL CRITICAL CARE AND TRANSPLANTATION SURGERY
UPDATED: August 2009 UCLA General Surgery Residency Program ROTATION: SURGICAL CRITICAL CARE AND TRANSPLANTATION SURGERY ROTATION DIRECTOR: Gerald Lipshutz, M.D. SITE: UCLA Medical Center LEVEL OF TRAINEE:
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney
More informationfollowing the last documented transfusion; thereafter, evaluate the residual impairment(s).
Adult Listings 5.01 Category of Impairments, Digestive System 5.02 Gastrointestinal hemorrhaging from any cause, requiring blood transfusion (with or without hospitalization) of at least 2 units of blood
More informationExtracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure
Extracorporeal Life Support Organization (ELSO) Guidelines for Pediatric Respiratory Failure Introduction This pediatric respiratory failure guideline is a supplement to ELSO s General Guidelines for all
More informationManagement of Cirrhosis Related Complications
Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this
More informationDialyzing challenging patients: Patients with hepato-renal conditions
Dialyzing challenging patients: Patients with hepato-renal conditions Nidyanandh Vadivel MD Medical Director for Living kidney Donor and Pancreas Transplant Programs Swedish Organ Transplant, Seattle Acute
More informationPACT module Acute hepatic failure. Intensive Care Training Program Radboud University Medical Centre Nijmegen
PACT module Acute hepatic failure Intensive Care Training Program Radboud University Medical Centre Nijmegen Acute Liver Failure Acute on Chronic Liver Failure Acute loss of hepatocellular function in
More informationDEPARTMENT OF SURGERY DIVISION OF ACUTE CARE SURGERY SURGICAL CRITICAL CARE ROTATION (SCC)
DEPARTMENT OF SURGERY DIVISION OF ACUTE CARE SURGERY SURGICAL CRITICAL CARE ROTATION (SCC) University Hospital House Officer I House Officer II House Officer III Curriculum/Rotation Goals and Objectives
More informationThe Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust
The Yellow Patient Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust there s a yellow patient in bed 40. It s one of yours. Liver Cirrhosis Why.When.What.etc.
More informationHigh-Acuity Nursing. Global edition. Global edition. Kathleen Dorman Wagner Melanie G. Hardin-Pierce
High-Acuity Nursing For these Global Editions, the editorial team at Pearson has collaborated with educators across the world to address a wide range of subjects and requirements, equipping students with
More informationEtiology of liver cirrhosis
Liver cirrhosis 1 Liver cirrhosis Liver cirrhosis is the progressive replacement of normal hepatic cells by fibrous scar tissue, This scarring is accompanied by the loss of viable hepatocytes, which are
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Activated partial thromboplastin time abnormality, perioperative approach to, 104 105 Acute kidney injury, perioperative, 89 99 early
More informationHemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.
Hemodynamic Disorders, Thrombosis, and Shock Richard A. McPherson, M.D. Edema The accumulation of abnormal amounts of fluid in intercellular spaces of body cavities. Inflammation and release of mediators
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives
Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced
More informationDESCRIPTIONS FOR MED 3 ROTATIONS Critical Care A2 ICU
Critical Care A2 ICU A. Neurological 1. Delirium Discuss the differential diagnosis and appropriate investigation for delirium. Provide non-pharmological and pharmological treatment options for delirium.
More informationWEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry
MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationIndex. Note: Page numbers of article titles are in boldface type
Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.
More informationManagement of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University
Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments
More informationIndex. Note: Page numbers of article numbers are in boldface type.
Index Note: Page numbers of article numbers are in boldface type. A Abdomen, acute, as cancer emergency, 381 399 in cancer patients, etiologies unique to, 390 392 in perforation, 388 surgery of, portal
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adverse drug events, polypharmacy and perioperative considerations in elderly patients, 377 389 Age, and risk of postoperative urinary retention,
More informationComplications of Cirrhosis
Complications of Cirrhosis Causes of Cirrhosis Alcohol Chronic Viral Hepatitis (B/C) Haemochromatosis Autoimmune Hepatitis NAFLD/NASH Primary Biliary Cirrhosis Primary Sclerosing Cholangitis 1-AT deficiency
More informationNYU School of Medicine Department of Radiology Rotation-Specific House Staff Evaluation
Vascular & Interventional Radiology Rotation 1 Core competency in vascular and interventional radiology during the first resident rotation consists of clinical objectives, technical objectives and image
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationPORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications
PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications Edy G. Trujillo, RN, MSN, ACNP-BC Liver Transplant RRUCLA Medical Center July 31, 2018 What Do We All Look Forward
More informationCirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association
CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS
More informationSupplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:
Supplemental Appendix 1. Protocol Definition of Sustained Virologic Response A patient has a sustained virologic response if: 1. The patient is a responder at the end of treatment and all subsequent planned
More informationNorepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome
Norepinephrine versus Terlipressin for the Treatment of Hepatorenal Syndrome Disclosure I have no conflicts of interest to disclose Name: Margarita Taburyanskaya Title: PharmD, PGY1 Pharmacy Practice Resident
More informationCIRRHOSIS Definition
Cirrhosis Update Robert S. Brown, Jr., MD, MPH Vice Chair, Transitions of Care Interim Chief, Division of Gastroenterology & Hepatology Weill Cornell Medical College CIRRHOSIS Definition Irreversible fibrous
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal tumors, in children, 530 531 Alkalinization, in tumor lysis syndrome, 516 Allopurinol, in tumor lysis syndrome, 515 Anaphylaxis, drug
More information-Cardiogenic: shock state resulting from impairment or failure of myocardium
Shock chapter Shock -Condition in which tissue perfusion is inadequate to deliver oxygen, nutrients to support vital organs, cellular function -Affects all body systems -Classic signs of early shock: Tachycardia,tachypnea,restlessness,anxiety,
More informationThis appendix was part of the submitted manuscript and has been peer. Pre-existing cardiovascular disease was defined by the presence of any of the
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors Additional methods Defining comorbidities Pre-existing cardiovascular disease
More informationEntrustable Professional Activity
Entrustable Professional Activity 1. EPA Title: Care of infants, children and adolescents with acute and chronic s 2. Description of Activity Practicing subspecialists must be trained to care for children
More informationBETA-BLOCKERS IN CIRRHOSIS.PRO.
BETA-BLOCKERS IN CIRRHOSIS.PRO. Angela Puente Sánchez. MD PhD Hepatology Unit. Gastroenterology department Marques de Valdecilla University Hospital. Santander INTRODUCTION. Natural history of cirrhosis
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abdominal radiotherapy, toxic effects of, 636 637 Acute promyelocytic leukemia, associated with acquired bleeding problems, 614 615 Acute renal
More informationNursing Care & Management of the Pre-Liver Transplant Population. Christine Kiamzon, RN, MSN, PCCN 8 North Educator
Nursing Care & Management of the Pre-Liver Transplant Population Christine Kiamzon, RN, MSN, PCCN 8 North Educator Objectives 1. Identify key nursing interventions in caring for pre-transplant ESLD patients.
More informationNursing Care & Management of the Pre-Liver Transplant Population
Nursing Care & Management of the Pre-Liver Transplant Population Christine Kiamzon, RN, MSN, PCCN 8 North Educator Objectives 1. Identify key nursing interventions in caring for pre-transplant ESLD patients.
More informationHepatopulmonary Syndrome: An Update
Hepatopulmonary Syndrome: An Update Michael J. Krowka MD Professor of Medicine Division of Pulmonary and Critical Care Division of Gastroenterology and Hepatology Mayo Clinic Falk Liver Week October 11,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acetaminophen, for geriatric surgical patients, 569 570 Acute kidney injury, critical care issues in geriatric patients with, 555 556
More informationDenver Shunts vs TIPS for Ascites
Denver Shunts vs TIPS for Ascites Hooman Yarmohammadi MD Assistant Professor of Radiology Interventional Radiology & Image Guided Therapies Memorial Sloan-Kettering Cancer Center, New York, USA Hooman
More informationOnline Supplementary Data. Country Number of centers Number of patients randomized
A Randomized, Double-Blind, -Controlled, Phase-2B Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients with Sepsis and Suspected Disseminated Intravascular
More informationAnesthesia for Liver Transplantation. Current Practice and Future Directions
Anesthesia for Liver Transplantation Current Practice and Future Directions U.S. Liver Transplants performed 1988-2002 Transplants 0 1000 2000 3000 4000 5000 Deceased Donor Living Donor 1988 1990 1992
More informationThe Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio
The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist K V Speeg, MD, PhD UT Health San Antonio Objectives Review staging of liver disease Review consequences of end-stage
More informationSupplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
More informationDISEASE LEVEL MEDICAL EVIDENCE PROTOCOL
DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols
More informationBeta-blockers in cirrhosis: Cons
Beta-blockers in cirrhosis: Cons Eric Trépo MD, PhD Dept. of Gastroenterology. Hepatopancreatology and Digestive Oncology. C.U.B. Hôpital Erasme. Université Libre de Bruxelles. Bruxelles. Belgium Laboratory
More informationTransplant Hepatology
Transplant Hepatology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified
More informationEvidence-Base Management of Esophageal and Gastric Varices
Evidence-Base Management of Esophageal and Gastric Varices Rino Alvani Gani Hepatobiliary Division Department of Internal Medicine Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo National
More informationCurrent Concepts in Diagnosis and Management of Acute Liver Failure
Current Concepts in Diagnosis and Management of Acute Liver Failure Oren Fix, MD, MSc, FACP, AGAF, FAASLD Medical Director, Liver Transplant Program Swedish Medical Center Seattle, WA Learning Objectives
More informationAscites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology
Ascites Management Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology Disclosure 1. The speaker Atif Zaman, MD MPH have no relevant
More informationDecompensated chronic liver disease
Decompensated chronic liver disease Definition of decompensated chronic liver disease Patients with chronic liver disease can present with acute decompensation due to various causes. The decompensation
More informationVirtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12:
Virtual Mentor American Medical Association Journal of Ethics December 2008, Volume 10, Number 12: 805-809. CLINICAL PEARL Indications for Use of TIPS in Treating Portal Hypertension Elizabeth C. Verna,
More information1. Discuss the basic pathophysiology of end-stage liver and kidney failure.
TRANSPLANT SURGERY ROTATION (PGY1, 2) A. Medical Knowledge Goal: The resident will achieve a detailed knowledge of the evaluation and treatment of a variety of disease processes. The resident will be exposed
More informationProgram Disclosure. This program is supported by an educational grant from Salix Pharmaceuticals.
Program Disclosure This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship
More informationSupplementary Digital Content
Geissler et al: Sirolimus and Hepatocellular Carcinoma in Liver Transplantation Page 1 of 10 Supplementary Digital Content Supplementary Table 1. Surgical procedures used Total Transplant technique Piggy
More informationDefinition: HPS is a disease process with a triad of: 1- Liver disease. 2- Widespread intrapulmonary vasodilatation. 3- Gas exchange abnormality prese
Hepatopulmonary syndrome (HPS) By Alaa Haseeb, MS.c Definition: HPS is a disease process with a triad of: 1- Liver disease. 2- Widespread intrapulmonary vasodilatation. 3- Gas exchange abnormality presenting
More informationהצגת מקרה- מפגש מכונים מאי 2017
הצגת מקרה- מפגש מכונים מאי 2017 ד " ר ד נ י פ ל ד מ ן - מ כ ו ן ג ס ט ר ו ה ל ל י פ ה 2004 38 years Ethiopian F. D+4. Hepatitis and pancytopenia Type 2 DM. Etihilism. low compliance Imaging (US, CT): Cirrhosis,
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationCOURSE OUTLINE Pathophysiology
Butler Community College Health, Education, and Public Services Division Denise LaKous Revised Spring 2014 Implemented Fall 2015 Textbook Update Fall 2015 COURSE OUTLINE Pathophysiology Course Description
More informationManagement of Ascites and Hepatorenal Syndrome. Florence Wong University of Toronto. June 4, /16/ Gore & Associates: Consultancy
Management of Ascites and Hepatorenal Syndrome Florence Wong University of Toronto June 4, 2016 6/16/2016 1 Disclosures Gore & Associates: Consultancy Sequana Medical: Research Funding Mallinckrodt Pharmaceutical:
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationPORTAL HYPERTENSION. Tianjin Medical University LIU JIAN
PORTAL HYPERTENSION Tianjin Medical University LIU JIAN DEFINITION Portal hypertension is present if portal venous pressure exceeds 10mmHg (1.3kPa). Normal portal venous pressure is 5 10mmHg (0.7 1.3kPa),
More informationYes No Unknown. Major Infection Information
Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery
More informationLiver-Kidney Crosstalk in Liver and Kidney Diseases
Liver-Kidney Crosstalk in Liver and Kidney Diseases Sundararaman Swaminathan MD Associate Professor Division of Nephrology University of Virginia Health System Charlottesville, VA Hepatonephrologist busily
More informationExample Clinician Educational Material for Providers of Immune Effector Cellular Therapy
Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy Disclaimer: This example is just one of many potential examples of clinician education material that can be provided
More informationSign up to receive ATOTW weekly -
HEPATORENAL SYNDROME ANAESTHESIA TUTORIAL OF THE WEEK 240 10 TH SEPTEMBER 2011 Gerry Lynch Rotherham General Hospital Correspondence to gerry.lynch@rothgen.nhs.uk QUESTIONS Before continuing, try to answer
More informationMichele Bettinelli RN CCRN Lahey Health and Medical Center
Michele Bettinelli RN CCRN Lahey Health and Medical Center Differentiate the types of varices Identify glue preparations utilized when treating gastric varices Review the process of glue administration
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs Hassanein T, Oliver D, Stange J, Steiner C Record Status This is a critical
More informationEASTERN ARIZONA COLLEGE Human Pathophysiology
EASTERN ARIZONA COLLEGE Human Pathophysiology Course Design 2016-2017 Course Information Division Allied Health Course Number HCE 240 Title Human Pathophysiology Credits 4 Developed by Dr. Robert Richman
More information4. Which survey program does your facility use to get your program designated by the state?
TRAUMA SURVEY Please complete one survey for each TCD designation you have in your facility. There would be a maximum of three surveys completed if your facility was designated as a trauma, stroke and
More informationDefinition: fibrosis and nodular regeneration resulting from hepatocellular injury
Cirrhosis Understanding the liver: Patterns of LFT Abnormalities - Hepatocellular/Transaminitis: o Ratio of AST: ALT >2:1 ETOH (keep in mind AST is also produced by red cells, heart muscle) o If Aminotransferases
More informationEvaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA
Evaluating HIV Patient for Liver Transplantation Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Slide 2 ESLD and HIV Liver disease has become a major cause of death
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Anemia(s), 412 426 categories in morphologic approach to, macrocytic, 412 414 microcytic, 412 414 normocytic, 412 413 categorizing, 412
More informationHepatorenal Syndrome
Necker Seminars in Nephrology Institut Pasteur Paris, April 22, 2013 Hepatorenal Syndrome Dr. Richard Moreau 1 INSERM U773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, 2 Université Paris Diderot
More informationLesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care
Lesta Whalen, MD Medical Director, Sanford ECMO Pediatric Critical Care Disclosures I have no financial disclosures. The use of certain devises for providing long-term cardiopulmonary support is investigational.
More informationAcute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018
Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support
More informationREVIEW. Ariel W. Aday, M.D.,* Nicole E. Rich, M.D.,* Arjmand R. Mufti, M.D., and Shannan R. Tujios, M.D.
REVIEW CON ( The Window Is Closed ): In Patients With Cirrhosis With Ascites, the Clinical Risks of Nonselective beta-blocker Outweigh the Benefits and Should NOT Be Prescribed Ariel W. Aday, M.D.,* Nicole
More informationDRG Code DRG Description FY18 Average Charge
DRG Code DRG Description FY18 Average Charge 3 ECMO OR TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W MAJ O $ 665,511 4 TRACH W MV 96+ HRS OR PDX EXC FACE, MOUTH & NECK W/O MAJ O.R. $ 422,497 37 EXTRACRANIAL
More informationSHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function
SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may
More informationAcute Liver Failure: Supporting Other Organs
Acute Liver Failure: Supporting Other Organs Michael A. Gropper, MD, PhD Professor of Anesthesia and Physiology Director, Critical Care Medicine University of California San Francisco Acute Liver Failure
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More information